{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:19:19Z","timestamp":1782490759789,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T00:00:00Z","timestamp":1339113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00702-012-0831-x","type":"journal-article","created":{"date-parts":[[2012,6,21]],"date-time":"2012-06-21T08:00:49Z","timestamp":1340265649000},"page":"1417-1423","source":"Crossref","is-referenced-by-count":12,"title":["The feasibility and safety of S-adenosyl-l-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trial"],"prefix":"10.1007","volume":"119","author":[{"given":"Tamar","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lital","family":"Steingart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Frisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Zarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Gothelf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,8]]},"reference":[{"issue":"6","key":"831_CR1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.jcp.0000145339.45794.cd","volume":"24","author":"JE Alpert","year":"2004","unstructured":"Alpert JE, Papakostas G, Mischoulon D, Worthington JJ 3rd, Petersen T, Mahal Y, Burns A, Bottiglieri T, Nierenberg AA, Fava M (2004) S-Adenosyl-l-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol 24(6):661\u2013664","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"831_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/cap.2006.0023","volume":"17","author":"A Aneja","year":"2007","unstructured":"Aneja A, Fremont WP, Antshel KM, Faraone SV, AbdulSabur N, Higgins AM, Shprintzen R, Kates WR (2007) Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome). J Child Adolesc Psychopharmacol 17(1):105\u2013114","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"831_CR3","first-page":"333","volume":"49","author":"KM Antshel","year":"2010","unstructured":"Antshel KM, Shprintzen R, Fremont W, Higgins AM, Faraone SV, Kates WR (2010) Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study. J Am Acad Child Adolesc Psychiatry 49(4):333\u2013344","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7\u20138","key":"831_CR4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.neuropharm.2009.07.025","volume":"57","author":"A Balcioglu","year":"2009","unstructured":"Balcioglu A, Ren JQ, McCarthy D, Spencer TJ, Biederman J, Bhide PG (2009) Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice. Neuropharmacology 57(7\u20138):687\u2013693","journal-title":"Neuropharmacology"},{"key":"831_CR5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/(SICI)1096-8628(19980710)81:4<328::AID-AJMG10>3.0.CO;2-N","volume":"81","author":"AS Bassett","year":"1998","unstructured":"Bassett AS et al (1998) 22q11 Deletion syndrome in adults with schizophrenia. Am J Med Genet 81:328\u2013337","journal-title":"Am J Med Genet"},{"issue":"12","key":"831_CR6","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jnnp.53.12.1096","volume":"53","author":"T Bottiglieri","year":"1990","unstructured":"Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH (1990) Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 53(12):1096\u20131098","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1 Pt 1","key":"831_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1542\/peds.112.1.101","volume":"112","author":"LD Botto","year":"2003","unstructured":"Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O\u2019Leary LA, Wong LY, Elixson EM, Mahle WT, Campbell RM (2003) A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112(1 Pt 1):101\u2013107","journal-title":"Pediatrics"},{"key":"831_CR8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1192\/bjp.154.1.48","volume":"154","author":"MW Carney","year":"1989","unstructured":"Carney MW, Chary TK, Bottiglieri T, Reynolds EH (1989) The switch mechanism and the bipolar\/unipolar dichotomy. Br J Psychiatry 154:48\u201351","journal-title":"Br J Psychiatry"},{"issue":"2","key":"831_CR9","first-page":"209","volume":"8","author":"SM Cohen","year":"1974","unstructured":"Cohen SM, Nichols A, Wyatt R, Pollin W (1974) The administration of methionine to chronic schizophrenic patients: a review of ten studies. Biol Psychiatry 8(2):209\u2013225","journal-title":"Biol Psychiatry"},{"issue":"1","key":"831_CR11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/appi.ajp.161.1.125","volume":"161","author":"A Diamond","year":"2004","unstructured":"Diamond A, Briand L, Fossella J, Gehlbach L (2004) Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry 161(1):125\u2013132","journal-title":"Am J Psychiatry"},{"issue":"5855","key":"831_CR12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.1151148","volume":"318","author":"A Diamond","year":"2007","unstructured":"Diamond A, Barnett WS, Thomas J, Munro S (2007) Preschool program improves cognitive control. Science 318(5855):1387\u20131388","journal-title":"Science"},{"issue":"1","key":"831_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1023087410712","volume":"20","author":"GAA DuPauI","year":"1998","unstructured":"DuPauI GAA, Power T, Reid R, Ikeda M, McGoey K (1998) Parent ratings of attention-deficit\/hyperactivity disorder symptoms: factor structure and normative data. J Psychopathol Behav Assess 20(1):83\u2013102","journal-title":"J Psychopathol Behav Assess"},{"issue":"4","key":"831_CR14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0006-3223(01)01231-8","volume":"51","author":"C Feinstein","year":"2002","unstructured":"Feinstein C, Eliez S, Blasey C, Reiss AL (2002) Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry 51(4):312\u2013318","journal-title":"Biol Psychiatry"},{"key":"831_CR15","volume-title":"User\u2019s guide for the structural clinical interview for DSM-IV Axis I disorders: research version","author":"M First","year":"1996","unstructured":"First M, Gibbon M, Spitezer R, Williams J (1996) User\u2019s guide for the structural clinical interview for DSM-IV Axis I disorders: research version. Biometric Research, New York"},{"issue":"11","key":"831_CR16","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1592\/phco.24.16.1501.50943","volume":"24","author":"JL Goren","year":"2004","unstructured":"Goren JL, Stoll AL, Damico KE, Sarmiento IA, Cohen BM (2004) Bioavailability and lack of toxicity of S-adenosyl-l-methionine (SAMe) in humans. Pharmacotherapy 24(11):1501\u20131507","journal-title":"Pharmacotherapy"},{"issue":"11","key":"831_CR17","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/nn1572","volume":"8","author":"D Gothelf","year":"2005","unstructured":"Gothelf D, Eliez S, Thompson T, Hinard C, Penniman L, Feinstein C, Kwon H, Jin S, Jo B, Antonarakis SE, Morris MA, Reiss AL (2005) COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 8(11):1500\u20131502","journal-title":"Nat Neurosci"},{"issue":"4","key":"831_CR18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.164.4.663","volume":"164","author":"D Gothelf","year":"2007","unstructured":"Gothelf D, Feinstein C, Thompson T, Gu E, Penniman L, Van Stone E, Kwon H, Eliez S, Reiss AL (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164(4):663\u2013669","journal-title":"Am J Psychiatry"},{"issue":"11","key":"831_CR19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/CHI.0b013e3181b76683","volume":"48","author":"T Green","year":"2009","unstructured":"Green T, Gothelf D, Glaser B, Debbane M, Frisch A, Kotler M, Weizman A, Eliez S (2009) Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry 48(11):1060\u20131068","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"831_CR20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/cap.2011.0042","volume":"21","author":"T Green","year":"2011","unstructured":"Green T, Weinberger R, Diamond A, Berant M, Hirschfeld L, Frisch A, Zarchi O, Weizman A, Gothelf D (2011) The effect of methylphenidate on prefrontal cognitive functioning, inattention, and hyperactivity in velocardiofacial syndrome. J Child Adolesc Psychopharmacol 21(6):589\u2013595","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"831_CR21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hup.989","volume":"24","author":"DW Hedges","year":"2009","unstructured":"Hedges DW, Brown BL, Shwalb DA (2009) A direct comparison of effect sizes from the clinical global impression-improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder. Hum Psychopharmacol 24(1):35\u201340","journal-title":"Hum Psychopharmacol"},{"issue":"4","key":"831_CR22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0091-3057(00)00274-4","volume":"66","author":"NS Lamango","year":"2000","unstructured":"Lamango NS, Charlton CG (2000) Farnesyl-l-cysteine analogs block SAM-induced Parkinson\u2019s disease-like symptoms in rats. Pharmacol Biochem Behav 66(4):841\u2013849","journal-title":"Pharmacol Biochem Behav"},{"key":"831_CR23","doi-asserted-by":"crossref","unstructured":"Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI (2011) Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder. Eur Psychiatry(in press)","DOI":"10.1016\/j.eurpsy.2011.03.006"},{"issue":"13","key":"831_CR24","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1021\/bi00013a008","volume":"34","author":"T Lotta","year":"1995","unstructured":"Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34(13):4202\u20134210","journal-title":"Biochemistry"},{"issue":"5","key":"831_CR25","doi-asserted-by":"crossref","first-page":"1158S","DOI":"10.1093\/ajcn\/76.5.1158S","volume":"76","author":"D Mischoulon","year":"2002","unstructured":"Mischoulon D, Fava M (2002) Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr 76(5):1158S\u20131161S","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 5","key":"831_CR26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4088\/JCP.8157su1c.04","volume":"70","author":"GI Papakostas","year":"2009","unstructured":"Papakostas GI (2009) Evidence for S-adenosyl-l-methionine (SAM-e) for the treatment of major depressive disorder. J Clin Psychiatry 70 (Suppl 5):18\u201322","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"831_CR27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/appi.ajp.2009.09081198","volume":"167","author":"GI Papakostas","year":"2010","unstructured":"Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M (2010) S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry 167(8):942\u2013948","journal-title":"Am J Psychiatry"},{"issue":"3","key":"831_CR28","first-page":"179","volume":"34","author":"N Shanee","year":"1997","unstructured":"Shanee N, Apter A, Weizman A (1997) Psychometric properties of the K-SADS-PL in an Israeli adolescent clinical population. Israel J Psychiatry Related Sci 34(3):179\u2013186","journal-title":"Israel J Psychiatry Related Sci"},{"issue":"1","key":"831_CR29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.euroneuro.2008.08.004","volume":"19","author":"RD Strous","year":"2009","unstructured":"Strous RD, Ritsner MS, Adler S, Ratner Y, Maayan R, Kotler M, Lachman H, Weizman A (2009) Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia. Eur Neuropsychopharmacol 19(1):14\u201322","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2\u20133","key":"831_CR31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.schres.2003.10.004","volume":"70","author":"T Amelsvoort van","year":"2004","unstructured":"van Amelsvoort T, Henry J, Morris R, Owen M, Linszen D, Murphy K, Murphy D (2004) Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr Res 70(2\u20133):223\u2013232","journal-title":"Schizophr Res"},{"key":"831_CR32","unstructured":"Wechsler D (1991) Wechsler Intelligence Scale for children, 3rd edn manual, Psychological Corp, San antonio, TX"},{"issue":"1\u20132","key":"831_CR33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0006-8993(00)03298-4","volume":"893","author":"P Werner","year":"2001","unstructured":"Werner P, Di Rocco A, Prikhojan A, Rempel N, Bottiglieri T, Bressman S, Yahr MD (2001) COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against l-dopa toxicity in vitro. Brain Res 893(1\u20132):278\u2013281","journal-title":"Brain Res"},{"key":"831_CR34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429\u2013435","journal-title":"Br J Psychiatry"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0831-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-012-0831-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-012-0831-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T01:03:22Z","timestamp":1561856602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-012-0831-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,8]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s00702-012-0831-x","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,8]]}}}